Status:
UNKNOWN
Clinical Effect of the Axillary Approach to Glenoid Fractures
Lead Sponsor:
Peking University Third Hospital
Conditions:
Fracture; Glenoid
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Glenoid fractures result in glenohumeral post-trauma arthritis and instability. Operative treatment is indicated for severe fractures. The traditional deltopectoral approach, which requires detachment...
Eligibility Criteria
Inclusion
- Traumatic and closed fractures
- Fracture type conforms to Ideberg Ia classification or AO/OTA F1.1 classification
- Fracture displacement ≥4mm, the area of involvement ≥20%.
Exclusion
- Severe multiple trauma
- Pathological fracture
- Unable to tolerate surgical treatment
- The interval between injury and operation was \> 2 weeks
Key Trial Info
Start Date :
June 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05279261
Start Date
June 12 2019
End Date
July 1 2022
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospita
Beijing, China, 100083